Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. DFTX
8. LLY
9. RGNX
10. LCO

Go back to Compugen Publishes Paper in Cancer Immunology Research on Unique Biology of PVRIG and its Therapeutic Potential

Compugen (CGEN) PT Raised to $5 at Truist Securities

May 20, 2024 1:21 PM EDT

Truist Securities analyst Asthika Goonewardene raised the price target on Compugen (NASDAQ: CGEN) to $5.00 (from $4.00) while maintaining a Buy rating.

The analyst comments "We are dismayed to learn that CGEN's efforts to develop COM701+COM902 in a particularly tough indication for immunotherapy... More